AstraZeneca scraps plan to expand vaccine plant in the UK
'AstraZeneca ditches vaccine plant' and Trump's EU tariff threat
The Financial Times leads on AstraZeneca's decision to scrap plans for a new vaccine manufacturing plant in Liverpool, calling it "a blow to the government's growth agenda". The paper says executives have warned that policies pursued by the government will make the UK a less attractive place to invest.
AstraZeneca has scrapped plans to invest £450m in expanding a vaccine manufacturing plant in Merseyside, blaming a reduction ...
AstraZeneca has abandoned a £450m investment in a major UK vaccine plant just days after Rachel Reeves vowed to “kick-start ...
AstraZeneca on Friday scrapped plans to invest 450 million pounds ($558.3 million) in its vaccine manufacturing plant in ...
Metro Mayor Steve Rotheram has said he is hoping to restart talks with AstraZeneca after it scrapped plans to invest £450m in ...
The government may have strong arguments for denying AstraZeneca's demands, but they may be harder to sustain given the ...
New Vision on MSN1d
AstraZeneca cancels UK plant after subsidies cutBRITISH pharmaceutical giant AstraZeneca said on Friday (Jan 31) that it was abandoning plans to build a £450 million ...
Rachel Reeves was dealt yet another blow after AstraZeneca cancelled a planned £450 million investment in a vaccine manufacturing plant. The chancellor came under fire on GB News for "making an ...
Several factors have influenced this decision including the timing and reduction of the final offer compared to the previous ...
The green light from the European Medicines Agency is the first backing in the EU for the medicine, following its approval in ...
Select listed pharma player including Pfizer, Novartis India, AstraZeneca Pharma and GSK Pharma shall be the beneficiaries of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback